EV/EBITDA
2.79
+0.07+2.57%
26 min ago
Summary
- As of February 7, 2025, OTLK EV/EBITDA is 2.79, with a rise of +0.07 (+2.57%) during the most recent trading day.
- Over the past year, OTLK EV/EBITDA has increased by +5.46 (+204.49%).
- OTLK EV/EBITDA is now -97.09% below its all-time high of 95.93.
Performance
OTLK EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
OTLK EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.6% | +2.6% | +3.5% |
| 1 m1 month | -18.9% | -19.0% | -23.9% |
| 3 m3 months | -66.3% | -66.3% | -73.6% |
| 6 m6 months | -96.3% | -65.4% | -75.6% |
| ytdytd | -6.7% | -6.8% | -8.8% |
| 1 y1 year | +204.5% | -57.0% | -79.2% |
| 5 y5 years | +296.5% | +5.2% | -91.1% |
OTLK EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -22.1% | 2.72 | +2.6% | |
| 3 m | 3-month | 8.27 | -66.3% | 2.29 | +21.8% |
| 6 m | 6-month | 83.19 | -96.7% | 2.29 | +21.8% |
| 1 y | 1-year | 95.93 | -97.1% | -5.76 | +148.4% |
| 3 y | 3-year | 95.93 | -97.1% | -8.62 | +132.4% |
| 5 y | 5-year | 95.93 | -97.1% | -16.32 | +117.1% |
| alltime | all time | 95.93 | -97.1% | -16.32 | +117.1% |
Outlook Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 2.79(-6.7%) |
| 2024 | 2.99(-217.7%) |
| 2023 | -2.54(-33.9%) |
| 2022 | -3.84(-22.7%) |
| 2021 | -4.97(+0.4%) |
| Date | Value |
|---|---|
| 2020 | -4.95(+438.0%) |
| 2019 | -0.92(-52.8%) |
| 2018 | -1.95(-15.9%) |
| 2017 | -2.32(+48.7%) |
| 2016 | -1.56 |
FAQ
- What is Outlook Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Outlook Therapeutics?
- What is OTLK EV/EBITDA year-to-date change?
- What is Outlook Therapeutics EV/EBITDA year-on-year change?
What is Outlook Therapeutics EV/EBITDA?
The current EV/EBITDA of OTLK is 2.79
What is the all time high EV/EBITDA for Outlook Therapeutics?
Outlook Therapeutics all-time high EV/EBITDA is 95.93
What is OTLK EV/EBITDA year-to-date change?
Outlook Therapeutics EV/EBITDA has changed by -0.20 (-6.69%) since the beginning of the year
What is Outlook Therapeutics EV/EBITDA year-on-year change?
Over the past year, OTLK EV/EBITDA has changed by +5.46 (+204.49%)